Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / United States — Food and Drug Administration / Dexcom

United States — Food and Drug Administration & Dexcom

2 shared events · Importance 3 · Last updated Dec 13, 2025

Importance
3
Shared Events
2
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
Shared Events (2)
0
Business
Dexcom Faces Class Action Lawsuits
Dexcom: Dexcom is facing multiple class action lawsuits for allegedly making unauthorized design changes to its G6 and G7 continuous glucose monitoring systems, leading to reliability issues and potential health risks for users. This has subjected Dexcom to increased regulatory scrutiny and significant financial and reputational harm.
Oct 30, 2025 · 43 articles
0
Regulatory
FDA Clears Dexcom Stelo for Children
Dexcom: Dexcom is the manufacturer of the Stelo Glucose Biosensor System, which received FDA clearance for pediatric use, potentially increasing its market share and revenue.
Jun 13, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how United States — Food and Drug Administration and Dexcom interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.